Home
/ eNeura
/ Competitors

eNeura Competitors and Similar CompaniesClear all

eNeura's competitors and similar companies include Seegene, Evergen, Emulate and OrthoPediatrics.

	eNeura eNeura Therapeutics, a medical technology company, develops transcranial magnetic stimulation devices for the treatment of migraines.	Seegene Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products.	Evergen Evergen (formerly known as RTI Surgical) is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.	Emulate Emulate is a biotechnology company that specializes in organ-on-chips technology.	OrthoPediatrics OrthoPediatrics designs, develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons.
Founding Date	Founding Date 2000	Founding Date 2000	Founding Date 1998	Founding Date 2014	Founding Date 2006
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices
Locations	Locations Baltimore, US HQ London, GB Sunnyvale, US	Locations Seoul, KR HQ Contagem, BR Toronto, CA Düsseldorf, DE Genova, IT Ciudad De México, MX Dubai, AE see more	Locations Alachua, US HQ Metz, FR Neunkirchen Am Brand, DE Houten, NL Singapore, SG Greenville, US Marquette, US see more	Locations Boston, US HQ	Locations Warsaw, US HQ
Employees	Employees 10	Employees 88478% increase	Employees 8915% decrease	Employees 802% decrease	Employees 9418% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₩474.2b (FY, 2025)	Revenue (est.) $280.9m (FY, 2018)	Revenue (est.) N/A	Revenue (est.) $236.3m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ₩133.4b (FY, 2025)	Cost of goods $140.7m (FY, 2018)	Cost of goods N/A	Cost of goods $63.7m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ₩345b (FY, 2025)	Gross profit $140.1m (FY, 2018)	Gross profit N/A	Gross profit $172.7m (FY, 2025)
Net income	Net income N/A	Net income ₩48.4b (FY, 2025)	Net income ($1.3m) (FY, 2018)	Net income N/A	Net income ($39.6m) (FY, 2025)
Operating ⚠
Countries	Countries N/A	Countries 48 (Q2, 2020)	Countries 45 (FY, 2016)	Countries N/A	Countries 36 (Nov, 2017)
Distributors	Distributors N/A	Distributors 100 (Q3, 2022)	Distributors N/A	Distributors N/A	Distributors 31 (Nov, 2017)
Funding
Latest funding round	Latest funding round $ 6.4m (over 10 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 36m (about 8 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 30.9m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 95m	Total funding raised $ 39m